Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 66401-66450 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05766891
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
PHASE2/PHASE3Recruiting
225 participants
Started: Oct 12, 2023 · Completed: Dec 31, 2028
1 condition3 sponsors1 location
NCT05893277
Harmony: A Combined MI and BCT Intervention to Reduce Intimate Partner Violence and Alcohol Use in South India
NARecruiting
800 participants
Started: Oct 12, 2023 · Completed: May 31, 2027
2 conditions4 sponsors1 location
NCT06043310
Estrogen and Microvascular Function
N/AActive, not recruiting
45 participants
Started: Oct 12, 2023 · Completed: Dec 31, 2031
4 conditions1 sponsor1 location
NCT06437730
Comparison of INIT and Dry Needling on Trigger Points in Knee OA
NARecruiting
36 participants
Started: Oct 12, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06183814
A Study of EXG102-031 in Participants With wAMD
PHASE1/PHASE2Recruiting
42 participants
Started: Oct 12, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor8 locations
NCT06083103
Contribution of PET/MRI in Locally Advanced Cervical Cancer (ATICC)
N/ARecruiting
50 participants
Started: Oct 12, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05732207
Cerebellar Involvement in Alcohol Use Disorder (AUD)
NARecruiting
122 participants
Started: Oct 12, 2023 · Completed: Sep 30, 2027
1 condition2 sponsors1 location
NCT06028984
Self-guided Treatment for Depression
NAActive, not recruiting
248 participants
Started: Oct 12, 2023 · Completed: Sep 30, 2025
1 condition3 sponsors1 location
NCT06109766
Delivering Evidence-Based Parenting Services to Families in Child Welfare Using Telehealth
NARecruiting
357 participants
Started: Oct 12, 2023 · Completed: Apr 12, 2028
4 conditions2 sponsors1 location
NCT06274008
Exparel vs. ACB With Bupivacaine for ACL Reconstruction
PHASE1Recruiting
96 participants
Started: Oct 12, 2023 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT05874375
UCon Treatment of Overactive Bladder (OAB) in Males
NARecruiting
20 participants
Started: Oct 12, 2023 · Completed: Jun 12, 2026
6 conditions1 sponsor1 location
NCT05754034
Building Respiratory Support in East Africa Through High Flow Versus Standard Flow Oxygen Evaluation
NARecruiting
1,054 participants
Started: Oct 11, 2023 · Completed: Oct 31, 2025
1 condition2 sponsors5 locations
NCT06290011
A Clinical Study on the Efficacy of Cognitive Distraction Focus Relaxation Therapy Based on MR
N/ARecruiting
132 participants
Started: Oct 11, 2023 · Completed: Jun 11, 2025
1 condition1 sponsor1 location
NCT05978791
Study on the Thrombolytic Effect of Platelet Membrane Coated Recombinant Staphylokinase on Human Arterial Thrombus
N/ARecruiting
24 participants
Started: Oct 11, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06203431
A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects
PHASE3Recruiting
270 participants
Started: Oct 11, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06487156
A Study to Evaluate First-line Ipilimumab + Nivolumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
N/ARecruiting
400 participants
Started: Oct 11, 2023 · Completed: Oct 11, 2030
1 condition1 sponsor1 location
NCT06439147
Comparison Between Two Techniques of Capsulotomy During Capsulorrhaphy in Cases of Developmental Dysplasia of the Hip
NAEnrolling by invitation
50 participants
Started: Oct 11, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06109649
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
PHASE3Active, not recruiting
200 participants
Started: Oct 11, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor30 locations
NCT06029114
MR Elastography of Cognitive Impairment
N/AEnrolling by invitation
450 participants
Started: Oct 11, 2023 · Completed: Nov 30, 2027
3 conditions2 sponsors1 location
NCT06219200
Automatic Voice Analysis for Dysphagia Screening in Neurological Patients
N/ARecruiting
400 participants
Started: Oct 11, 2023 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT05978362
Value of Capsular Repair for Latarjet
NARecruiting
86 participants
Started: Oct 11, 2023 · Completed: Dec 31, 2034
1 condition2 sponsors1 location
NCT05961098
A Study of RBD1016 in CHB Participants
PHASE2Active, not recruiting
48 participants
Started: Oct 11, 2023 · Completed: Dec 15, 2025
1 condition1 sponsor4 locations
NCT05878015
A Study of Intravenous Acetaminophen for Small Bowel Obstruction
PHASE4Enrolling by invitation
18 participants
Started: Oct 11, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06062589
AK104 Combined With I-125 Brachytherapy for Recurrent or Metastatic Cervical Cancer
N/ANot yet recruiting
18 participants
Started: Oct 11, 2023 · Completed: Oct 11, 2027
1 condition1 sponsor0 locations
NCT05724823
Virtual Physical Activity Seated Exercise - Phase 2
NARecruiting
100 participants
Started: Oct 11, 2023 · Completed: Dec 31, 2026
4 conditions3 sponsors5 locations
NCT06333067
Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators
NARecruiting
100 participants
Started: Oct 11, 2023 · Completed: Nov 1, 2025
1 condition1 sponsor2 locations
NCT06106646
Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
N/ARecruiting
225 participants
Started: Oct 11, 2023 · Completed: Aug 31, 2028
4 conditions3 sponsors2 locations
NCT05979337
Brief Interventions in Chronic Migraine
NARecruiting
300 participants
Started: Oct 11, 2023 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT06257290
The Role of Platelet TLRs in Platelet Activation During VTE
N/ARecruiting
100 participants
Started: Oct 11, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05932589
Neurophysiologic Biomarkers in Rett Syndrome
N/ARecruiting
202 participants
Started: Oct 11, 2023 · Completed: Mar 31, 2029
3 conditions3 sponsors6 locations
NCT06112340
Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
PHASE2/PHASE3Recruiting
75 participants
Started: Oct 11, 2023 · Completed: Jun 30, 2026
12 conditions1 sponsor2 locations
NCT05972525
What Matters to Patients With Severe Hip or Knee Osteoarthritis?
NAActive, not recruiting
615 participants
Started: Oct 11, 2023 · Completed: Jul 11, 2026
2 conditions2 sponsors3 locations
NCT06012240
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
PHASE3Recruiting
1,500 participants
Started: Oct 11, 2023 · Completed: Jan 31, 2028
1 condition1 sponsor267 locations
NCT06206161
Optimizing and Advancing SBIRT in Schools
NAEnrolling by invitation
18,000 participants
Started: Oct 11, 2023 · Completed: Nov 11, 2027
3 conditions4 sponsors1 location
NCT05501704
ETHAN - ET for Male BC
PHASE2Recruiting
60 participants
Started: Oct 11, 2023 · Completed: Apr 1, 2036
3 conditions3 sponsors7 locations
NCT05681650
HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors
PHASE1/PHASE2Recruiting
30 participants
Started: Oct 11, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05537220
Oral N-acetylcysteine for Retinitis Pigmentosa
PHASE3Active, not recruiting
483 participants
Started: Oct 11, 2023 · Completed: May 31, 2029
1 condition32 sponsors31 locations
NCT05914090
The Application of Enhanced Recovery After Surgery (ERAS) for Cardiovascular Surgery in Adult
NANot yet recruiting
3,600 participants
Started: Oct 11, 2023 · Completed: Dec 30, 2024
2 conditions1 sponsor2 locations
NCT06085508
Fear of MOVEment After MI and AF - InterneT Patient Education
NARecruiting
14 participants
Started: Oct 11, 2023 · Completed: Feb 29, 2024
3 conditions5 sponsors1 location
NCT06083610
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes
N/ARecruiting
34 participants
Started: Oct 11, 2023 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT06052852
Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies
PHASE1Active, not recruiting
147 participants
Started: Oct 11, 2023 · Completed: Mar 31, 2028
7 conditions2 sponsors6 locations
NCT05832229
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
PHASE2Recruiting
256 participants
Started: Oct 11, 2023 · Completed: Nov 30, 2028
8 conditions15 sponsors13 locations
NCT06353555
Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage
NARecruiting
100 participants
Started: Oct 11, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06455046
Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer
PHASE2Recruiting
37 participants
Started: Oct 11, 2023 · Completed: Oct 10, 2025
1 condition2 sponsors1 location
NCT06022549
Effects of mHealth Message on Metabolic Syndrome and Bone Loss of HIV Infected Persons in Taiwan
N/ARecruiting
400 participants
Started: Oct 11, 2023 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT06386276
Surgical TReatment of Women With Deep ENDometriosis
N/ARecruiting
250 participants
Started: Oct 11, 2023 · Completed: Jun 30, 2029
2 conditions1 sponsor1 location
NCT05922930
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
PHASE1/PHASE2Recruiting
51 participants
Started: Oct 11, 2023 · Completed: Jan 15, 2028
3 conditions1 sponsor1 location
NCT06052098
Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer
NARecruiting
110 participants
Started: Oct 11, 2023 · Completed: Oct 31, 2027
1 condition2 sponsors1 location
NCT06087965
Fingolimod in Minimal Invasive Treatment of Intracerebral Hemorrhage
PHASE1/PHASE2Not yet recruiting
40 participants
Started: Oct 11, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor0 locations
NCT06451172
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial Keratitis
EARLY_PHASE1Recruiting
20 participants
Started: Oct 11, 2023 · Completed: Oct 31, 2026
10 conditions2 sponsors1 location